3Lee WM. Hepatitis B virus infection[J]. N Engl J Med, 1997,337(24) :1733.
4Niesters HG, Honkoop P, Haagsma EB, et al. Identification of more than one mutation in the hepatitis B vires polymerase gene arising during prolonged lamivudine treatment[J]. J Infect Dis, 1998,177(5) : 1382.
5Allen MI, Deslauriers M, Andrews CW, et al. ldontiiqeation and characterlzation of mutations in hepatitis B virus resistant to lamivudine [ J].Hepatology, 1998,27(6) : 1670.
6Melegari M,Scaglioni PP,Wands JR. Hepatitis B virus mutants associated with 3TC and Famciclovir administration are replication defective[J].Hepatology, 1998,27(2) :628.
7Ono-Nita SK, Kato N, Shiratori Y, et al. YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistence: A study by in vitro full-length viral DNA transfection[J]. Hepatology, 1999,29(3) :939.
8Atkins M, Hunt CM, Brown N, et al. Clinical significance of YMDD mutara hepatitis B virus in a large cohort of lamivudlne-tleated hepatitis B patients[J], nepatology, 1998,28(Suppl 1) :319A.
9Fu L,Cheng YC. Role ff additional mutations outside the YMDD motif of hepatitis B virus polymerase in L ( - ) SddC ( 3TC ) resistance [ J ] .Biochem Pharmacol, 1998,55(10) : 1567.
10Honkoop P, Niesters HG,de Man RA, et al. Iamivudine resistance in irmmmoeompetent chronic hepatitis B. Incidence and patterns [ J ]. J Hepatol, 1997,26(6) : 1393.
2Chayama K, Suzuki Y, Kobayashi M, et al. Emergence and takeover of YMDD motif mutanl hepatitis B virus during long-term lamivudine therapy and re takeover by wild type after cessation of therapy. Hepatology,1998,27:1711-1716.
3Stuyver L, Van Geyt C, De Gendt S, et al. lane probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol, 2000, 38: 702-707.
4Lau DT, Khokhar MF, Doo E, et al. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology, 2000,32: 828-834.
5Zoutim F. Detection of hepatitis B virus resistance to antivirals. J Clin Virol, 2001, 21:243-253.
6Ozer E, Helvaci M, Yaprak I. Hepatic expression of viral antigens, hepatocytic proliferative activity and histologic changes in liver biopsies of children with chronic hepatitis B after interferon alpha therapy. Liver, 1999,19:369-374.
7[1]Williams EJ,Iredale P. LiverCirrhosis[J].Postgrad-Med-J, 1998,74(870):193-202.
8[6]Kweon Yo, Goodman ZD, Dienstag JL, et al. Dereasing Fibro-genesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B[J].Hepatol,2001,35(6):749-755.
10Chayama K,Suzuki Y,Kobaysbi M,et al.Emergence and takeover of YMDD motif mutant of hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after lessation of therapy,Hepatology,1998,27:1711-1716.
